Abnormalities in metabolism, cardiac conduction times, and an increased risk of type 2 diabetes have been raised as concerns with antipsychotic medications, along with serious long-term neurological side effects.
Abnormaliteter i stofskiftet og en øget risiko for type 2-diabetes er blevet nævnt som en bekymring ved disse medikamenter sammen med mere alvorlige langsigtede neurologiske bivirkninger.